Daniel W Lin

6PUBLICATIONS

82CO-AUTHORS

Predictive and prognostic markersMolecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (6)

Sort by Publication Date:

|May 26, 2026

Integrative Surface Antigen Profiling of KLK2 and STEAP1 in Advanced Prostate Cancer.

|Aug 19, 2024

Upgrading of Grade Group 1 Prostate Cancer at Prostatectomy: Germline Risk Factors in a Prospective Cohort.

Michael A Liss, Nicole Zeltser, Yingye Zheng

|Oct 12, 2023

Concurrent Targeting of HDAC and PI3K to Overcome Phenotypic Heterogeneity of Castration-resistant and Neuroendocrine Prostate Cancers.

Ailin Zhang, Nathan A Lau, Alicia Wong

|Jan 11, 2022

Considerations on Integrating Prostate-Specific Membrane Antigen Positron Emission Tomography Imaging Into Clinical Prostate Cancer Trials by National Clinical Trials Network Cooperative Groups.

Heiko Schöder, Thomas A Hope, Michael Knopp

|Oct 13, 2020

Newly Diagnosed High-Risk Prostate Cancer in an Era of Rapidly Evolving New Imaging: How Do We Treat?

Maha Hussain, Daniel Lin, Fred Saad

|Aug 12, 2020

Optimizing the management of castration-resistant prostate cancer patients: A practical guide for clinicians.

Neal D Shore, Charles G Drake, Daniel W Lin

Pageof 1

Frequent Collaborators

Eva Corey

John K Lee

Peter S Nelson

Lawrence D True

Colm Morrissey

Ilsa M Coleman

Evan Y Yu

Fred Saad

Sean Sachdev

Neal D Shore

Frequent Collaborators

Eva Corey

John K Lee

Peter S Nelson

Lawrence D True